The Eli Lilly-backed antibody discovery platform developer's shares opened at more than three times their IPO price to net it a valuation topping $15bn.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Google and existing investor Novo contributed to a series G2 round valuing the precision medicine developer at $8.1bn post-money.

Sidewalk Labs' health provision spinoff took its valuation above $1bn and its overall funding to about $300m in a General Catalyst-led series C round.

The series D round helped Sedgwick and NewYork-Presbyterian-backed care optimisation platform developer LeanTaas push its overall funding past the $250m mark.

The mitochondrial disease therapy developer's latest round was co-led by Novo Ventures and backed by returning investor Lundbeckfonden Ventures.

Rex Healthcare’s venture capital unit will exit the cancer diagnostics system developer, which has agreed to an acquisition by Olympus.

The CCC Marketing-backed salon operator has set a range for an initial public offering set to net it between $16.8m and $19.2m.

Tencent invested $15.3m in gene therapy-focused research services provider Obio Technology in its third funding round of 2020.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.